SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-089631
Filing Date
2023-11-22
Accepted
2023-11-22 16:49:04
Documents
13
Period of Report
2023-11-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea188870-8k_avalonglobo.htm   iXBRL 8-K 26623
2 MEMBERSHIP INTEREST PURCHASE AGREEMENT, DATED NOVEMBER 17, 2023, BETWEEN AVALON ea188870ex10-1_avalonglobo.htm EX-10.1 119805
  Complete submission text file 0001213900-23-089631.txt   346198

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE albt-20231117.xsd EX-101.SCH 3039
4 XBRL LABEL FILE albt-20231117_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE albt-20231117_pre.xml EX-101.PRE 22375
7 EXTRACTED XBRL INSTANCE DOCUMENT ea188870-8k_avalonglobo_htm.xml XML 3418
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 231434111
SIC: 2836 Biological Products, (No Diagnostic Substances)